This quarterly report represents an earnings surprise of 20%. A quarter ago, it was expected that this pharmaceutical and medical device company would post earnings of $0.17 per share when it actually produced earnings of$0.22, delivering a surprise of 29.41%. CorMedix (CRMD) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of$0.25 per share. This compares to loss of $0.25 per share a year ago. These figures are adjusted for non- recurring items. Empirical research ...